Cyp3a Inducers + Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen Interaction
Majorinteraction on record
Description
Coadministration may result in decreased plasma concentrations of RPV and loss of virologic response with possible resistance to RPV or NNRTIs.
Mechanism
RPV is primarily metabolized by CYP3A; inducers increase clearance
Source: NLP:emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide